INOOlab

INOOlab is the commercial preventive-diagnostics offering of Austrian diagnostics company Fianostics, built on the company's FluoBolt platform for highly sensitive biomarker testing. The company markets laboratory-based antibody testing solutions that can work from very small blood samples and has emphasized pharmacy-enabled access and home-compatible sample collection. Its best-described commercial product is a SARS-CoV-2 antibody test branded under INOOlab, which combines Fianostics assay technology with microsampling collection hardware from Neoteryx. Beyond the branded INOOlab offering, Fianostics states that it develops and produces R&D assays for biomarkers and also performs contract development under ISO 13485 quality standards. Overall, this is best characterized as a small private Austrian diagnostics company rather than a therapeutics developer.